Day: June 7, 2024

BATON ROUGE, La., June 07, 2024 (GLOBE NEWSWIRE) — Marucci Sports LLC, a wholly owned subsidiary of Fox Factory Holding Corp. (Nasdaq: FOXF), announced today that it has entered into a license agreement with Major League Baseball (MLB) for its Marucci and Victus brands to exclusively be the Official Bats of MLB. In addition, the agreement provides for the exclusive rights to use MLB trademarks in connection with Marucci’s Smart Bat products featuring the embedded Diamond Kinetics bat sensor. The exclusive license will begin on January 1, 2025, and continue until December 31, 2028. This agreement with MLB exemplifies the leadership position of Marucci and Victus brands as the premier bat choices worldwide, as they are the top two most-used bats among MLB players and have long been part of the MLB landscape. Another brand in Marucci...

BEIJING, June 07, 2024 (GLOBE NEWSWIRE) — ATA Creativity Global (“ACG” or the “Company”, Nasdaq: AACG), an international educational services company focused on providing quality learning experiences that cultivate and enhance students’ creativity, today announced that the Company received a written letter from the Nasdaq Stock Market LLC (“Nasdaq”) dated May 29, 2024, notifying the Company that it no longer meets the minimum bid price requirement set forth in Nasdaq Listing Rules for continued listing on the Nasdaq as the closing bid price for the Company’s American depositary shares (“ADSs”) listed on the Nasdaq was below US$1.00 for 30 consecutive business days. Nasdaq Listing Rule 5450(a)(1) requires listed securities to maintain a minimum bid price of US$1.00 per share, and Nasdaq Listing Rule 5810(c)(3)(A) provides that a...

LAS VEGAS, June 07, 2024 (GLOBE NEWSWIRE) — Live Ventures Incorporated (Nasdaq: LIVE), a diversified holding company (“Live Ventures” or “Company”), today announced that its Board of Directors approved a new stock repurchase program authorizing the Company to repurchase up to $10 million of the Company’s outstanding shares of common stock. This new repurchase program replaces the previous program that expired on June 1, 2024, and will remain effective until May 31, 2025, unless extended, canceled, or modified by the Company’s Board of Directors. The shares may be repurchased at management’s discretion from time to time in open market transactions, including through block purchases, through privately negotiated transactions, or pursuant to any trading plan that may be adopted in accordance with Rule 10b5-1 of the Securities Exchange...

SHANGHAI, June 07, 2024 (GLOBE NEWSWIRE) — Hywin Holdings Ltd. (“Hywin Wealth”, “Hywin”, or the “Company”) (NASDAQ: HYW), today announced that an annual general meeting (the “AGM”) of the Company will be held through a conference call on Friday, June 28, 2024, at 10:00 a.m., Beijing time (or 10:00 p.m. Thursday, June 27, 2024, Eastern Time). No proposal will be submitted for shareholder approval at the AGM. The record date (the “Record Date”) for determining the shareholders entitled to receive notice of the AGM or any adjournment or postponement thereof has been set as the close of business on June 6, 2024. Holders of record of our ordinary shares at the close of business on the Record Date are entitled to attend the AGM and any adjournment or postponement thereof in person. Beneficial...

Applied Digital secures a $125 million initial commitment to fund ongoing construction costs associated with its HPC Campus in Ellendale, ND, which can be upsized upon mutual agreement by both parties up to $200 million This financing completes the Company’s near-term capital needs and positions it to secure project-level financing to fund the remaining costs to complete the first HPC building Financing provides the Company with a clear path to solidifying its position as a leading HPC datacenter owner and operatorDALLAS, June 07, 2024 (GLOBE NEWSWIRE) — Applied Digital Corporation (Nasdaq: APLD) (“Applied Digital” or the “Company”), a designer, builder, and operator of next-generation digital infrastructure designed for High-Performance Computing (“HPC”) applications, announced today that the Company...

Not for distribution to U.S. newswire services or dissemination in the United States.All dollar amounts are in Canadian dollars unless otherwise indicated‎. VANCOUVER, British Columbia, June 07, 2024 (GLOBE NEWSWIRE) — HydroGraph Clean Power Inc. (CSE: ‎HG) (OTCQB: HGCPF) (the “Company” or “HydroGraph”) ‎is pleased to announce that, due to strong investor demand, it has increased the size of its non-brokered private placement of units (the “Units”) previously announced on May 22, 2024 (the “Offering”). Pursuant to the upsized Offering, the Company will raise aggregate gross proceeds of up to $3.2M at a price of $0.16 per Unit. “We are extremely pleased to announce upsizing of our non-brokered private placement and the strong investing interest we have received from shareholders and new investors, reflecting their confidence in...

SalMar ASA (rated BBB+ by Nordic Credit Rating) has issued a new commercial paper of NOK 650,000,000. Issue date: 14 June 2024Maturity date: 13 September 2024Coupon: 5.12 % p.a.Manager: DNB Markets For further information, please contact:Håkon Husby, Head of Investor RelationsTel: +47 936 30 449Email: hakon.husby@salmar.no About SalMar SalMar is one of the world’s largest and most efficient producers of salmon. The Group has farming operations in Central Norway, Northern Norway and Iceland, as well as substantial harvesting and secondary processing operations. In addition, the company is operating within offshore aquaculture through the company SalMar Aker Ocean and SalMar owns 50% of the shares in Scottish Sea Farms Ltd. See www.salmar.no for more information about the company. This information is subject to the disclosure requirements...

Analytical testing has confirmed optimal formulation for upcoming studies SARASOTA, FL, June 07, 2024 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on developing novel formulations and drug delivery systems for traditional therapeutics and psychedelic treatments, today announced a successful series of development activities for the Company’s SP-26 ketamine implant therapeutic targeting fibromyalgia and chronic pain. An ongoing pre-clinical research study of SP-26 is underway involving analytical testing services and small batch proof-of-concept extrusion trials for the ketamine hydrochloride (ketamine HCL) implants at 20% and 40% drug load. The Company previously reported that the initial testing provided validation of the delivery system based...